Loading
Latest filing published 28 Sept 2026 for Kura Oncology, Inc., €44k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
One trade, one date: on 28 September 2026, Doyle Thomas James disclosed a transaction of €44k in Kura Oncology, Inc. No broader history exists yet. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration